Comprehensive Stock Comparison

Compare Cibus, Inc. (CBUS) vs BlackRock Technology and Private Equity Term Trust (BTX) Stock

Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Try these comparisons:

Quick Verdict

CategoryWinnerWhy
GrowthCBUS logoCBUS134.6% revenue growth vs BTX's -81.1%
Quality / MarginsBTX logoBTX87.7% net margin vs CBUS's -31.3%
Stability / SafetyBTX logoBTXBeta 1.16 vs CBUS's 1.89
DividendsBTX logoBTX12.9% yield; 1-year raise streak; CBUS pays no meaningful dividend
Momentum (1Y)CBUS logoCBUS+49.3% vs BTX's +6.8%
Efficiency (ROA)BTX logoBTX1.8% ROA vs CBUS's -36.0%, ROIC 1.4% vs -86.2%
Bottom line: BTX leads in 4 of 6 categories, making it the stronger pick for investors who prioritize profitability and margin quality and capital preservation and lower volatility. Cibus, Inc. is the better choice for growth and revenue expansion and recent price momentum and sentiment. As direct sector peers, they can serve as alternatives in the same portfolio allocation.

Who Each Stock Is For

Income & stability

Growth exposure

Long-term compounding (10Y)

Sleep-well-at-night portfolio

Defensive / Recession hedge

Business Model

What each company does and how it makes money

CBUSCibus, Inc.
Healthcare

Cibus is an agricultural technology company that develops and licenses proprietary plant traits to seed companies. It generates revenue primarily through royalty payments from seed sales — typically 5-15% of seed revenue — with additional income from upfront licensing fees and research collaborations. The company's moat lies in its proprietary gene-editing platform that enables rapid, precise trait development without introducing foreign DNA, giving it a technological edge over traditional breeding methods.

BTXBlackRock Technology and Private Equity Term Trust
Healthcare

BlackRock Technology and Private Equity Term Trust is a closed-end investment fund that pools investor capital to invest primarily in mid- and small-capitalization growth companies in the technology and healthcare sectors. It generates returns through capital appreciation and dividend income from its equity portfolio, with performance tied to the success of its underlying investments. The fund's key advantage is BlackRock's extensive research capabilities and access to innovative companies that traditional investors might overlook.

Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CBUSCibus, Inc.
FY 2024
Reportable Segment
100.0%$4M
BTXBlackRock Technology and Private Equity Term Trust

Segment breakdown not available.

Financial Metrics Comparison

Side-by-side fundamentals across 2 stocks. BestLagging

Financial Scorecard

BTX logoBTX 4CBUS logoCBUS 1
Financial MetricsBTX logoBTX4/4 metrics
Valuation MetricsCBUS logoCBUS2/3 metrics
Profitability & EfficiencyBTX logoBTX7/8 metrics
Total ReturnsBTX logoBTX4/6 metrics
Risk & VolatilityBTX logoBTX2/2 metrics
Analyst Outlook0/0 metrics

BTX leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). CBUS leads in 1 (Valuation Metrics).

Financial Metrics (TTM)

BTX is the larger business by revenue, generating $41M annually — 10.7x CBUS's $4M. BTX is the more profitable business, keeping 87.7% of every revenue dollar as net income compared to CBUS's -31.3%.

MetricCBUS logoCBUSCibus, Inc.BTX logoBTXBlackRock Technol…
RevenueTrailing 12 months$4M$41M
EBITDAEarnings before interest/tax-$87M
Net IncomeAfter-tax profit-$119M
Free Cash FlowCash after capex-$52M
Gross MarginGross profit ÷ Revenue+63.3%+100.0%
Operating MarginEBIT ÷ Revenue-24.5%+87.7%
Net MarginNet income ÷ Revenue-31.3%+87.7%
FCF MarginFCF ÷ Revenue-13.6%+6.8%
Rev. Growth (YoY)Latest quarter vs prior year-63.1%
EPS Growth (YoY)Latest quarter vs prior year+94.2%
BTX leads this category, winning 4 of 4 comparable metrics.

Valuation Metrics

MetricCBUS logoCBUSCibus, Inc.BTX logoBTXBlackRock Technol…
Market CapShares × price$99M$773M
Enterprise ValueMkt cap + debt − cash$121M$773M
Trailing P/EPrice ÷ TTM EPS-0.31x38.94x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple21.64x
Price / SalesMarket cap ÷ Revenue23.17x18.99x
Price / BookPrice ÷ Book value/share0.79x0.80x
Price / FCFMarket cap ÷ FCF2.79x
CBUS leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

BTX delivers a 1.9% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-2 for CBUS. On the Piotroski fundamental quality scale (0–9), CBUS scores 4/9 vs BTX's 3/9, reflecting mixed financial health.

MetricCBUS logoCBUSCibus, Inc.BTX logoBTXBlackRock Technol…
ROE (TTM)Return on equity-2.3%+1.9%
ROA (TTM)Return on assets-36.0%+1.8%
ROICReturn on invested capital-86.2%+1.4%
ROCEReturn on capital employed-60.6%+1.8%
Piotroski ScoreFundamental quality 0–943
Debt / EquityFinancial leverage0.37x
Net DebtTotal debt minus cash$22M$0
Cash & Equiv.Liquid assets$14M
Total DebtShort + long-term debt$36M$0
Interest CoverageEBIT ÷ Interest expense-2.69x2313.25x
BTX leads this category, winning 7 of 8 comparable metrics.

Total Returns (with DRIP)

A $10,000 investment in BTX five years ago would be worth $5,453 today (with dividends reinvested), compared to $91 for CBUS. Over the past 12 months, CBUS leads with a +49.3% total return vs BTX's +6.8%. The 3-year compound annual growth rate (CAGR) favors BTX at 5.8% vs CBUS's -46.5% — a key indicator of consistent wealth creation.

MetricCBUS logoCBUSCibus, Inc.BTX logoBTXBlackRock Technol…
YTD ReturnYear-to-date+77.1%+0.5%
1-Year ReturnPast 12 months+49.3%+6.8%
3-Year ReturnCumulative with dividends-84.7%+18.3%
5-Year ReturnCumulative with dividends-99.1%-45.5%
10-Year ReturnCumulative with dividends-99.4%-45.5%
CAGR (3Y)Annualised 3-year return-46.5%+5.8%
BTX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

BTX is the less volatile stock with a 1.16 beta — it tends to amplify market swings less than CBUS's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricCBUS logoCBUSCibus, Inc.BTX logoBTXBlackRock Technol…
Beta (5Y)Sensitivity to S&P 5001.89x1.16x
52-Week HighHighest price in past year$3.80$7.50
52-Week LowLowest price in past year$1.09$5.10
% of 52W HighCurrent price vs 52-week peak+87.6%+88.3%
RSI (14)Momentum oscillator 0–10067.047.3
Avg Volume (50D)Average daily shares traded401K908K
BTX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

BTX is the only dividend payer here at 12.93% yield — a key consideration for income-focused portfolios.

MetricCBUS logoCBUSCibus, Inc.BTX logoBTXBlackRock Technol…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$11.50
# AnalystsCovering analysts3
Dividend YieldAnnual dividend ÷ price+12.9%
Dividend StreakConsecutive years of raises11
Dividend / ShareAnnual DPS$0.86
Buyback YieldShare repurchases ÷ mkt cap0.0%+12.0%
Insufficient data to determine a leader in this category.

Historical Charts

Charts are rendered on first load. Hover for details.

Chart 1Total Return — 5 Years (Rebased to 100)

StockApr 21Mar 26Change
Cibus, Inc. (CBUS)1001.18-98.8%
BlackRock Technolog… (BTX)102.6533.57-67.3%

BlackRock Technolog… (BTX) returned -45% over 5 years vs Cibus, Inc. (CBUS)'s -99%.

Chart 2Revenue Growth — 10 Years

Stock20152024Change
Cibus, Inc. (CBUS)$1M$4M+235.1%
BlackRock Technolog… (BTX)$-640M$41M+106.4%

Cibus, Inc.'s revenue grew from $1M (2015) to $4M (2024) — a 14.4% CAGR.

Chart 3Net Margin Trend — 10 Years

Stock20152024Change
Cibus, Inc. (CBUS)-4.6%-59.0%-1174.0%
BlackRock Technolog… (BTX)100.1%87.7%-12.4%

Cibus, Inc.'s net margin went from -5% (2015) to -59% (2024).

Chart 4EPS Growth — 10 Years

Stock20152024Change
Cibus, Inc. (CBUS)-11.07-10.83+2.2%
BlackRock Technolog… (BTX)-2.580.17+106.6%

Cibus, Inc.'s EPS grew from $-11.07 (2015) to $-10.83 (2024).

Chart 5Free Cash Flow — 5 Years

2021
$-19M
$-5B
2022
$-21M
$310M
2023
$-51M
$217M
2024
$-59M
$277M
Cibus, Inc. (CBUS)BlackRock Technolog… (BTX)

Cibus, Inc. generated $-59M FCF in 2024 (-205% vs 2021). BlackRock Technology and Private Equity Term Trust generated $277M FCF in 2024 (+106% vs 2021).

Loading custom metrics...

CBUS vs BTX: Frequently Asked Questions

7 questions · data-driven answers · updated daily

01

Is CBUS or BTX a better buy right now?

BlackRock Technology and Private Equity Term Trust (BTX) offers the better valuation at 38.9x trailing P/E, making it the more compelling value choice. Analysts rate Cibus, Inc. (CBUS) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CBUS or BTX?

Over the past 5 years, BlackRock Technology and Private Equity Term Trust (BTX) delivered a total return of -45.5%, compared to -99.1% for Cibus, Inc. (CBUS). A $10,000 investment in BTX five years ago would be worth approximately $5K today (assuming dividends reinvested). Over 10 years, the gap is even starker: BTX returned -45.5% versus CBUS's -99.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CBUS or BTX?

By beta (market sensitivity over 5 years), BlackRock Technology and Private Equity Term Trust (BTX) is the lower-risk stock at 1.16β versus Cibus, Inc.'s 1.89β — meaning CBUS is approximately 62% more volatile than BTX relative to the S&P 500.

04

Which has better profit margins — CBUS or BTX?

BlackRock Technology and Private Equity Term Trust (BTX) is the more profitable company, earning 87.7% net margin versus -59.0% for Cibus, Inc. — meaning it keeps 87.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTX leads at 87.7% versus -60.6% for CBUS. At the gross margin level — before operating expenses — CBUS leads at 100.0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

05

Which pays a better dividend — CBUS or BTX?

In this comparison, BTX (12.9% yield) pays a dividend. CBUS does not pay a meaningful dividend and should not be held primarily for income.

06

Is CBUS or BTX better for a retirement portfolio?

For long-horizon retirement investors, BlackRock Technology and Private Equity Term Trust (BTX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.16), 12.9% yield). Cibus, Inc. (CBUS) carries a higher beta of 1.89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BTX: -45.5%, CBUS: -99.4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

07

What are the main differences between CBUS and BTX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: CBUS is a small-cap quality compounder stock; BTX is a small-cap income-oriented stock. BTX pays a dividend while CBUS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.

📊
Stocks Like

CBUS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 37%
Run This Screen
🛡️
Stocks Like

BTX

Dividend Mega-Cap Quality

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 52%
  • Dividend Yield > 5.1%
Run This Screen